Ignite Creation Date:
2024-07-17 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497985
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-06-28
Brief Title:
Phase III Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSSpMMR Colorectal Cancer Patients
Sponsor:
Organization:
Chipscreen Biosciences Ltd